Related Experiment Video
Updated: Aug 8, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor
Zhiwei He1, Yong-Yeon Cho, Guangming Liu
1Hormel Institute, University of Minnesota, Austin, Minnesota 55912, USA.
Abstract:
The relationship between cell transformation and p38 MAP kinase, a major mitogen-activated protein (MAP) kinase pathway converting signals of various extracellular stimuli into expression of specific target genes through activation of transcription factors, still remains unclear. The aim of the present study was to investigate the role of the p38 MAP kinase pathway in epidermal growth factor (EGF)-induced cell transformation in JB6 cells. Our data show that a dominant negative mutant of p38 MAP (DN-p38) kinase inhibits EGF-promoted JB6 Cl41 cell transformation and that SB202190, an inhibitor of p38 MAP kinase, also inhibits JB6 Cl41 cell transformation in a dose-dependent manner. Moreover, our results show that DN-p38 MAP kinase inhibits the phosphorylation of EGF-stimulated activating transcription factor-2 (ATF-2) and signal transducer and activator of transcription 1 (STAT1). Additionally, DN-p38 MAP kinase inhibits EGF-induced phosphorylation of c-Myc (Thr58/Ser62). Gel shift assays indicate that DN-p38 MAP kinase inhibits EGF-induced activator protein-1 (AP-1) DNA binding in a dose-dependent manner. These results show that p38 MAP kinase plays a key role in the regulation of EGF-induced cell transformation in JB6 cells through regulation of phosphorylation of p38 MAP kinase and activation of its target genes in phosphorylation, c-Myc cell transformation-related genes, and AP-1 binding ability.
Insights
The p38 MAP kinase pathway is crucial for epidermal growth factor (EGF)-induced cell transformation in JB6 cells. Inhibiting this pathway blocks cell transformation by affecting key transcription factors like ATF-2, STAT1, c-Myc, and AP-1.
Area of Science:
- Cell Biology
- Molecular Biology
- Signal Transduction
Background:
- The role of p38 MAP kinase pathway in cell transformation is not fully understood.
- Epidermal growth factor (EGF) is known to induce cell transformation in JB6 cells.
Purpose of the Study:
- To investigate the role of the p38 MAP kinase pathway in EGF-induced cell transformation in JB6 cells.
Main Methods:
- Utilized a dominant negative mutant of p38 MAP kinase (DN-p38) and SB202190, a p38 MAP kinase inhibitor.
- Assessed the effects on EGF-promoted JB6 Cl41 cell transformation.
- Examined the phosphorylation of ATF-2, STAT1, and c-Myc.
- Performed gel shift assays to evaluate activator protein-1 (AP-1) DNA binding.
Main Results:
- DN-p38 MAP kinase and SB202190 significantly inhibited EGF-induced JB6 Cl41 cell transformation.
- DN-p38 MAP kinase reduced the phosphorylation of EGF-stimulated ATF-2 and STAT1.
- DN-p38 MAP kinase inhibited EGF-induced phosphorylation of c-Myc.
- DN-p38 MAP kinase dose-dependently inhibited EGF-induced AP-1 DNA binding.
Conclusions:
- p38 MAP kinase is a key regulator of EGF-induced cell transformation in JB6 cells.
- This regulation involves the modulation of p38 MAP kinase phosphorylation and the activation of downstream targets including c-Myc and AP-1.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
TGF - β Signaling Pathway
Mitogens and the Cell Cycle

